8Saini A,Norman AR,Cunningham D,et al.Twelve weeks of protracted venous infusion of fluorouracil (5-Fu) and folinic acid as adjuvant treatment in colorectal cancer.Br J Cancer,2003,88(12):1859-1865.
5Tjandra JJ, Kilkenny JW, Buie WD, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum,2005,48 : 411-423.
6Karapetis CS, Khambata FS, Jonker DJ, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med ,2008,359 : 1757-1765.
7Lievre A, Bachet JB, Boige V, et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol,2008,26:374-379.
8Van Cutsem E, Kohne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med ,2009,360 : 1408-1418.
10Zubrod CG, Schneiderman SM, Frei E, et al. Appraisal of methodsfor the study of chemotherapy of cancer in man: Comparativetherapeutic trial of nitrogen mustard and thiophosphamide. J Chronic Dis, 1960,11:7-33.
